TEVA Trademark

Trademark Overview

On Tuesday, February 23, 2016, a trademark application was filed for TEVA with the United States Patent and Trademark Office. The USPTO has given the TEVA trademark a serial number of 86916562. The federal status of this trademark filing is REGISTERED as of Tuesday, March 31, 2020. This trademark is owned by Teva Pharmaceutical Industries Limited. The TEVA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical consulting services in the field of pharmaceuticals; Providing healthcare information by telephone, the internet, global computer networks and electronic means regarding the therapeutic management and therapeutic use of medical treatment; Home-visit nursing care
teva

General Information

Serial Number86916562
Word MarkTEVA
Filing DateTuesday, February 23, 2016
Status700 - REGISTERED
Status DateTuesday, March 31, 2020
Registration Number6024389
Registration DateTuesday, March 31, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 20, 2016

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the wording "TEVA" in stylized form where the letter "V" is formed from two diamond shaped leaves.
Goods and ServicesMedical consulting services in the field of pharmaceuticals; Providing healthcare information by telephone, the internet, global computer networks and electronic means regarding the therapeutic management and therapeutic use of medical treatment; Home-visit nursing care
Translation of Words in MarkThe English translation of "TEVA" in the mark is "NATURE"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, February 27, 2016
Primary Code044
First Use Anywhere DateMonday, February 26, 2018
First Use In Commerce DateMonday, February 26, 2018

Trademark Owner History

Party NameTeva Pharmaceutical Industries Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressTel Aviv 6944020
IL
Party NameTeva Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPetach Tikva 49131
IL
Party NameTeva Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events

Event DateEvent Description
Friday, October 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 31, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, February 26, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 25, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 4, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 4, 2020NON-FINAL ACTION E-MAILED
Tuesday, February 4, 2020SU - NON-FINAL ACTION - WRITTEN
Friday, January 17, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 14, 2020USE AMENDMENT FILED
Tuesday, January 14, 2020TEAS STATEMENT OF USE RECEIVED
Friday, August 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 8, 2019EXTENSION 5 GRANTED
Tuesday, August 6, 2019EXTENSION 5 FILED
Thursday, August 8, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 6, 2019TEAS EXTENSION RECEIVED
Saturday, February 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 7, 2019EXTENSION 4 GRANTED
Thursday, February 7, 2019EXTENSION 4 FILED
Thursday, February 7, 2019TEAS EXTENSION RECEIVED
Thursday, August 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 7, 2018EXTENSION 3 GRANTED
Tuesday, August 7, 2018EXTENSION 3 FILED
Tuesday, August 7, 2018TEAS EXTENSION RECEIVED
Saturday, February 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2018EXTENSION 2 GRANTED
Thursday, February 8, 2018EXTENSION 2 FILED
Thursday, February 8, 2018TEAS EXTENSION RECEIVED
Thursday, February 8, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 7, 2017EXTENSION 1 GRANTED
Monday, August 7, 2017EXTENSION 1 FILED
Monday, August 7, 2017TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 7, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 7, 2016EXAMINER'S AMENDMENT ENTERED
Monday, November 7, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 7, 2016EXAMINERS AMENDMENT E-MAILED
Monday, November 7, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 25, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 25, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 25, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 16, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 16, 2016NON-FINAL ACTION E-MAILED
Thursday, June 16, 2016NON-FINAL ACTION WRITTEN
Tuesday, June 7, 2016ASSIGNED TO EXAMINER
Tuesday, March 1, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, February 27, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 26, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

teva therapeutic medical regarding electronic means management care nursing visit treatment